| Prisma Health Patewood Hospital | |
| 175 Patewood Drive, Greenville, South Carolina 29615 | |
| (864) 797-1000 | |
| Name | Prisma Health Patewood Hospital |
|---|---|
| Type | Acute Care Hospital |
| Location | 175 Patewood Drive, Greenville, South Carolina |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | No |
| Medicare ID (CCN) | 420102 |
| NPI Number | 1033664909 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH VASCULAR HEALTH ALLIANCE |
| Address | 200 Patewood Dr, Suite C300, Greenville, SC 29615 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-454-8272 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1114473212 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CANCER INST-FARIS |
| Address | 900 W Faris Rd, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-679-3900 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1124574223 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH PATEWOOD HOSPITAL |
| Address | 175 Patewood Dr, Greenville, SC 29615 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-797-1000 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1144775032 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH OP SURGERY PATEWOOD |
| Address | 200 Patewood Dr, Building A, Greenville, SC 29615 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-454-2604 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1174079271 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CENTER FOR FAMILY MEDICINE |
| Address | 877 W Faris Rd, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-7800 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1366998460 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CARDIOVASCULAR SVCS GRNV |
| Address | 3 Butternut Dr, Suite B4, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-6900 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1407301211 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH OB/GYN CLINIC |
| Address | 1120 Grove Rd, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-6444 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1437605532 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CENTER FOR PEDIATRIC MED |
| Address | 20 Medical Ridge Dr, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-522-5220 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1508312604 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH OP SURGERY CROSS CREEK |
| Address | 9 Doctors Dr, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-8400 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1568532513 |
| Organization Name | GREENVILLE HEALTH SYSTEM |
| Doing Business As | GHS PATEWOOD MEMORIAL HOSPITAL |
| Address | 175 Patewood Dr, Greenville, SC 29615 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-797-1000 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1649033077 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH GASTROENTEROLOGY & LIVER CENTER |
| Address | 890 W Faris Rd Ste 100, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-2888 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1659134070 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Address | 10 Halton Green Way, Greenville, SC 29607 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-675-5000 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1659827756 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CANCER INST-GROVE |
| Address | 3 Butternut Dr, Suite B, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-241-7272 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1679029771 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CANCER INST-EASTSIDE |
| Address | 65 International Dr, Greenville, SC 29615 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-987-7000 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1689129496 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH PEDS MULTIDISCIPLINARY CLINIC |
| Address | 900 W Faris Rd, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-8898 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1720747496 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH TRANSPLANT CENTER |
| Address | 890 W Faris Rd Ste 510, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-1770 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1851846661 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH CTR FOR PED & INT MED-WEST |
| Address | 5 W Main St, Greenville, SC 29611 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-522-5300 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1922788728 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Address | 905 Verdae Blvd Ste 102, Greenville, SC 29607 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-522-6600 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1932654704 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Doing Business As | PRISMA HEALTH SURGERY/ORTHOPEDICS CLINIC |
| Address | 13 Edgewood Dr, Greenville, SC 29605 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-455-7861 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| NPI Number | 1952163339 |
| Organization Name | PRISMA HEALTH-UPSTATE |
| Address | 155b Halton Village Cir, Greenville, SC 29607 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 864-522-4500 |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
The Cardiovascular Research Foundation (CRF) will present results of the largest meta-analysis to date comparing mortality rates for drug-eluting stents (DES) versus bare metal stents (BMS) at the Drug-Eluting Stent Revolution VII meeting tomorrow evening in Chicago.
The COVID-19 pandemic has reversed years of global progress in tackling tuberculosis and for the first time in over a decade, TB deaths have increased, according to the World Health Organization's 2021 Global TB report.
Massachusetts' largest private employer Partners HealthCare on Friday warned that the state could face a federal lawsuit if it implements a proposed rule to increase some companies' contributions to their workers' health coverage, the Boston Globe reports.
› Verified 1 days ago
St Francis-downtown Acute Care Hospital Location: One St Francis Dr, Greenville, South Carolina 29601 Phone: (800) 805-5678 | |
Prisma Health Greenville Memorial Hospital Acute Care Hospital Location: 905 Verdae Blvd Suite 102, Greenville, South Carolina 29605 Phone: (864) 455-7000 | |
Prisma Health Patewood Hospital Acute Care Hospital Location: 175 Patewood Drive, Greenville, South Carolina 29615 Phone: (864) 797-1000 | |
Shriners Hospitals For Children Childrens Hospital Location: 950 West Faris Road, Greenville, South Carolina 29605 Phone: (864) 271-3444 |